Evidence map›Paper›PMID 35027833›Full record

ArticleClinicoEconomics and outcomes research : CEOR2022

Issue with Evaluating Costs Over Time in a Context of Medical Guideline Changes: An Example in Myocardial Infarction Care Based on a Longitudinal Study from 1997 to 2018.

Tania Villeneuve, Xavier Trudel, Mahée Gilbert-Ouimet, Jacinthe Leclerc, Alain Milot, Hélène Sultan-Taïeb, Chantal Brisson, Jason Robert Guertin

Open access · goldAbstract read
In one paragraph

Article in ClinicoEconomics and outcomes research : CEOR, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Tania VilleneuveUniversité Laval, Département de médecine sociale et préventive, Quebec City, Canada.
Xavier TrudelUniversité Laval, Département de médecine sociale et préventive, Quebec City, Canada.
Mahée Gilbert-OuimetCentre de recherche du Centre hospitalier universitaire de l'Université Laval, Quebec City, Canada.
Jacinthe LeclercUniversité du Québec à Trois-Rivières, Département des sciences infirmières, Trois-Rivières, Canada.
Alain MilotUniversité Laval, Département de médecine, Quebec City, Canada.
Hélène Sultan-TaïebUniversité du Québec à Montréal (UQAM), School of Management, Montreal, Canada.
Chantal BrissonUniversité Laval, Département de médecine sociale et préventive, Quebec City, Canada.
Jason Robert GuertinUniversité Laval, Département de médecine sociale et préventive, Quebec City, Canada.ORCID 0000-0003-1718-5307
Centre hospitalier de l'Université Laval · CAUniversité Laval · CAInstitut universitaire de cardiologie et de pneumologie de Québec · CAUniversité du Québec à Montréal · CAUniversité du Québec à Rimouski · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCost studies appear sporadically in the scientific literature and are rarely revised unless drastic technological advancements occur. However, health technologies and medical guidelines evolve over time. It is unclear if these changes render obsolete prior estimates. We examined this issue in a cost study in the context of patients' first myocardial infarction (MI), a clinical area prone to such continuous evolution in care.

methodsWe conducted a longitudinal cost analysis based on a Quebec cohort. Quebec health administrative databases were used to identify incident MI cases using diagnostic codes from the international classification of diseases (ICD-9 and ICD-10). Physician fees and hospitalization costs (ie, costs incurred by the hospital center) were derived from administrative databases and a university hospital's finance department. All costs were converted to 2019 Canadian dollars. Nonparametric bootstraps were used to estimate 95% confidence intervals (CI) of the average costs of an episode of care. Generalized linear regressions were used to examine temporal trends of cost.

resultsOur study sample consists of 261 patients hospitalized for a first MI. The average total cost for this first event was estimated at $5782 (95% CI: $5293 - $6373). Though total costs remained stable over time, physician fees increased by 123% ($1240 vs $2761) whereas total hospital length of stay dropped by 17% (6.6 vs 5.5 days) over the 21-year period.

conclusionPatients' first MI hospitalization impose an economic burden on the healthcare system. Though overall costs remained stable, our results suggest that some cost components varied over time.

Indexed as

cost studylongitudinal studymethodsmyocardial infarctionobservational data

Identifiers

PMID35027833
PMCPMC8751975
OpenAlexW4205403076

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.